Abstract:Clostridium difficile infection (CDI) arises in the setting of antibiotic administration where disruption of the normal indigenous gut microbiota leads to susceptibility to C. difficile colonization and colitis. Using a murine model of CDI, we demonstrate that changes in the community structure of the indigenous gut microbiota are associated with the loss of colonization resistance against C. difficile. Several antibiotic regimens were tested in combination for the ability to overcome colonization resistance, including a five antibiotic cocktail consisting of kanamycin, gentamicin, colistin, metronidazole, and vancomycin administered in drinking water for three days, a single intraperitoneal dose of clindamycin or 10 days of cefoperazone in drinking water. Following antibiotic treatment animals were challenged with 105 colony forming units of C. difficile strain VPI 10463 via oral gavage. Animals that received the antibiotic cocktail and clindamycin prior to C. difficile challenge followed one of two clinical courses, either becoming clinically ill and moribund within 2-4 days post challenge, or remaining clinically well. Animals that became clinically ill developed histologically severe colitis. These histopathologic findings were significantly less severe in animals that remained clinically well. Analysis of 16S rRNA gene sequences retrieved from gut tissue at necropsy demonstrated that Proteobacteria dominated the gut microbiota in clinically ill animals. In contrast, the gut microbial community of clinically well animals more closely resembled untreated animals, which were dominated by members of the Firmicutes. All animals that received cefoperazone treatment prior to C. difficile challenge were clinically ill and moribund by 2-5 days post challenge in a dose dependent manner. The gut communities in these animals were dominated by C.difficile suggesting that cefoperazone treatment resulted in a greater loss in colonization resistance. Thus, the severity of colitis that arises in this system reflects the interplay between the expansion of C. difficile in the gut community and the ecologic dynamics of the indigenous microbial community as it recovers from antibiotic perturbation. We demonstrate that altering the balance of these two opposing processes alters clinical outcome and thus may lead to novel preventative and therapeutic approaches for CDI.

A computational method to dissect colonization resistance of the gut microbiota against pathogens

Decoding the microbiome: advances in genetic manipulation for gut bacteria

Mechanism of the Gut Microbiota Colonization Resistance and Enteric Pathogen Infection

Genome-guided design of a defined mouse microbiota that confers colonization resistance against Salmonella enterica serovar Typhimurium

Personalized engraftment risk prediction and probiotic therapy assessment in the human gut

Selective Colonization Ability of Human Fecal Microbes in Different Mouse Gut Environments

Possible link between colonization of the gastrointestinal tract by Citrobacter rodentium in C57BL/6 mice and microbiota composition

Colonization resistance: the role of gut microbiota in preventing Salmonella invasion and infection

Dissecting Individual Interactions between Pathogenic and Commensal Bacteria within a Multispecies Gut Microbial Community

An Ecological Framework to Understand the Efficacy of Fecal Microbiota Transplantation

The protective role of commensal gut microbes and their metabolites against bacterial pathogens

Cryptic Colonization and Transmission of Mcr-1-positive Escherichia Coli in Mouse Intestines

Towards Optimal Microbiome to Inhibit Multidrug Resistance

Species and genus level resolution analysis of gut microbiota in Clostridium difficile patients following fecal microbiota transplantation

A Toolbox for Genetic Manipulation in Intestinal Clostridium Symbiosum

Integrating gut microbiome and host immune markers to understand the pathogenesis of Clostridioides difficile infection

Dissecting Gut‐Microbial Community Interactions using a Gut Microbiome‐on‐a‐Chip

Mouse models for bacterial enteropathogen infections: insights into the role of colonization resistance

Metabolic Engineering of Commensal Bacteria for Gut Butyrate Delivery and Dissection of Host-Microbe Interaction.

Elucidating human gut microbiota interactions that robustly inhibit diverse Clostridioides difficile strains across different nutrient landscapes

The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile Infection